potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet [K-Phos No 2]
RxNorm concept 209224, branded drug (sbd). Prescribable name: K-Phos No 2 305 MG / 700 MG Oral Tablet.
- RxCUI
- 209224
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/209224 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
K+ phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet [K-Phos No 2]; K-Phos No 2 (potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG) Oral Tablet; Pot phosphate 305 MG / Sodium Phosphate, Monobasic 700 MG Oral Tablet [K-Phos No 2]
Related concepts
- sodium phosphate, monobasic 700 MG (SCDC, consists of)
- potassium phosphate 305 MG (SCDC, consists of)
- potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG [K-Phos No 2] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- K-Phos No 2 (BN, has ingredient)
- potassium phosphate 305 MG / sodium phosphate, monobasic 700 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 209224 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/209224 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 209224. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.